EC Number |
Inhibitors |
Structure |
---|
5.3.99.3 | (1-benzyl-4-dodecanoyl-3,5-dimethyl-1H-pyrrol-2-yl)acetic acid |
35% inhibition at 0.001 mM |
|
5.3.99.3 | (2E)-2-(2,5-bis[2-[4-(trifluoromethyl)phenyl]ethoxy]benzylidene)hexanoic acid |
- |
|
5.3.99.3 | (2E)-2-(2,5-bis[[4-(trifluoromethyl)benzyl]oxy]benzylidene)hexanoic acid |
55.1% residual activity at 0.01 mM |
|
5.3.99.3 | (2E)-2-[2,5-bis(2-cyclohexylethoxy)benzylidene]hexanoic acid |
- |
|
5.3.99.3 | (2E)-2-[2,5-bis(2-phenylethoxy)benzylidene]hexanoic acid |
- |
|
5.3.99.3 | (2E)-2-[4-[3-(2,3-dimethylphenoxy)propoxy]benzylidene]hexanoic acid |
28.3% residual activity at 0.01 mM |
|
5.3.99.3 | (2E)-2-[5-(2-cyclohexylethoxy)-2-[[4-(trifluoromethyl)benzyl]oxy]benzylidene]hexanoic acid |
74% residual activity at 0.01 mM |
|
5.3.99.3 | (2R)-2-([4-[3-(2,3-dimethylphenoxy)propoxy]phenyl]sulfanyl)hexanoic acid |
- |
|
5.3.99.3 | (2S)-2-([4-[3-(2,3-dimethylphenoxy)propoxy]phenyl]sulfanyl)hexanoic acid |
- |
|
5.3.99.3 | (3R)-1-(7-chloro-2-[2-chloro-5-[(2-methylpropanamido)methyl]phenyl]-4-oxo-3,4-dihydroquinazolin-6-yl)pyrrolidin-3-yl acetate |
- |
|